Cannabidiol

Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?

ABSTRACT Movement disorders such as Parkinson’s disease and dyskinesia are highly debilitating conditions linked to oxidative stress and neurodegeneration. When available, the pharmacological therapies for these disorders are still mainly symptomatic, do not benefit all patients and induce severe side effects. Cannabidiol is a non-psychotomimetic compound from Cannabis sativa that presents antipsychotic, anxiolytic, anti-inflammatory, and …

Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders? Read More »

Efficacy of dietary hempseed oil in patients with atopic dermatitis.

ABSTRACT Levels of both essential fatty acids (EFAs), linoleic acid (18:2n6) and alpha-linolenic acid (18:3n3), and gamma-linolenic acid (GLA; 18:3n6) increased in all lipid fractions after hempseed oil, with no significant increases of arachidonic acid (20:4n6) in any lipid fractions after either oil. Intra-group TEWL values decreased (p=0.074), qualities of both skin dryness and itchiness …

Efficacy of dietary hempseed oil in patients with atopic dermatitis. Read More »

Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis.

ABSTRACT CBD targets enteric reactive gliosis, counteracts the inflammatory environment induced by LPS in mice and in human colonic cultures derived from UC patients. These actions lead to a reduction of intestinal damage mediated by PPARgamma receptor pathway. Our results therefore indicate that CBD indeed unravels a new therapeutic strategy to treat inflammatory bowel diseases. …

Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis. Read More »

Scroll to Top
Scroll to Top